Chinese Journal of Cancerindexed by SCI
《癌症》杂志
BMC

About the cover
About the cover

Jun. 2017; Volume 36 Issue 6

June 1996, Matthew Scott discovers a gene responsible for basal cell carcinoma, the most common human cancer.
June 2006, FDA approves Gardasil, a vaccine that protects against the virus that causes most cervical cancers.


Research Highlight
Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer
Dong Wang, Ruikai Du and Suling Liu
[ Abstract  281]  [ PDF Full-text  247]   [ HTML Full-text  193]    Epub: 2017-4-1  doi: 10.1186/s40880-017-0204-9
Editorial
The 150 most important questions in cancer research and clinical oncology series: questions 31-39
Editorial Office of the Chinese Journal of Cancer
[ Abstract  458]  [ PDF Full-text  183]   [ HTML Full-text  77]    Epub: 2017-6-2  doi: 10.1186/s40880-017-0215-6
Review
Immunological effect of local ablation combined with immunotherapy on solid malignancies
Yusuke Takahashi, Noriyuki Matsutani, Takashi Nakayama, Hitoshi Dejima, Hirofumi Uehara and Masafumi Kawamura
[ Abstract  440]  [ PDF Full-text  343]   [ HTML Full-text  188]    Epub: 2017-6-7  doi: 10.1186/s40880-017-0216-5
Original Article
CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China
Yanfen Feng, Huilan Rao, Yiyan Lei, Yuhua Huang, Fang Wang, Yu Zhang, Shaoyan Xi, Qiuliang Wu and Jianyong Shao
[ Abstract  439]  [ PDF Full-text  220]   [ HTML Full-text  117]    Epub: 2017-5-10  doi: 10.1186/s40880-017-0212-9
Association between DNA mismatch repair gene polymorphisms and platinum-based chemotherapy toxicity in non-small cell lung cancer patients
Jun-Yan Liu, Chen-Yue Qian, Yuan-Feng Gao, Juan Chen, Hong-Hao Zhou and Ji-Ye Yin
[ Abstract  370]  [ PDF Full-text  379]   [ HTML Full-text  333]    Epub: 2017-1-17  doi: 10.1186/s40880-016-0175-2
Weekly taxane-anthracycline combination regimen versus tri-weekly anthracycline-based regimen for the treatment of locally advanced breast cancer: a randomized controlled trial
Qiu-Wen Tan, Ting Luo, Hong Zheng, Ting-Lun Tian, Ping He, Jie Chen, He-Lin Zeng and Qing Lv
[ Abstract  311]  [ PDF Full-text  334]   [ HTML Full-text  317]    Epub: 2017-3-8  doi: 10.1186/s40880-017-0196-5
Correspondence
Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers
Kadri Altundag
[ Abstract  238]  [ PDF Full-text  203]   [ HTML Full-text  179]    Epub: 2017-5-16  doi: 10.1186/s40880-017-0208-5




CJC Wechat 微信公众号

CJC触屏版


 

Editorial Manager


CJC adopts Editorial Manager to manage its submissions from Dec.18, 2014
 

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CJC is now published by BioMed Central

© Chinese Journal of Cancer

Sun Yat-sen University Cancer Center

651 Dongfeng Road East, Guangzhou 510060, P. R. China